Isolation of Specific DNA Variants Using Biotinylated dD-Loops
|
Target DNA |
Supercoiled plasmid |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Colonies (presep) |
Colonies (postsep) |
|||||||||||||
| Target Plasmids |
% Kan CNV (SNaP) |
Kan |
Amp |
% Kan CNV Kan/Amp |
Kan |
Amp |
% Kan CNV Kan/Amp |
Relaxed %Kan CNV Kan/Amp |
||||||
| pKan+ (tat) | — | 1124 | 1188 | 95% | 48 | 63 | 76% | 0% | ||||||
| pKan- (tag) | — | 0 | 448 | 0% | 0 | 0 | 0% | 0% | ||||||
| CNV B1 (tag-tac) | 5% | 60 | 570 | 10% | 53 | 128 | 42% | >90% | ||||||
| CNV D3 (tag-tac) | 69% | 363 | 437 | 83% | 164 | 183 | 90% | >90% | ||||||
| CNV D5 (tag-tac)
|
10%
|
90
|
520
|
17%
|
28
|
38
|
74%
|
>90%
|
||||||
-
Shown in the table are results from an adaptation of our capture method that is capable of isolating sequences that differ by as little as 1 nt. The first two columns from the left describe five different plasmid targets that were used and the starting proportion of Kancnv sequence in the sample: two plasmids that differ by only a single nucleotide, (1) pWE15 KanR carrying a wild-type kanamycin gene (TAT codon): (2) pWE15 Kan5 carrying a mutant kanamycin gene (TAG codon); and three plasmid samples with a mixture of plasmids carrying a mutant kanamycin gene TAG codon) and a conservative replacement (Kancnv) that confers the KanR phenotype (TAC codon)—(3) pWE15(CNVB1), (4) pWE15(CNVD3), (5) pWE15(CNVD5). Two different preparations of these plasmid samples were used as templates for the capture assay, either supercoiled or topoisomerase I relaxed cccDNA. In each of these plasmid forms, results are presented before separation (Colonies presep) and after the biotin-labeled complexes were separated by binding to strepavidin-conjugated paramagnetic beads (Colonies postsep) for each preparation. The numbers presented are actual colony numbers obtained after transforming equal samples of each condition into bacteria and replica plating for kanamycin (Kan) and ampicillin (Amp) LB plates and the proportion of Kan to Amp (% Kan CNV).











